Anticancer efficacies of cisplastin-releasing pH-responsive nanoparticles

Biomacromolecules

Volumn 7, Issue 3, 2006, Pages 829-835

  Xu, Peisheng ^a   Van Kirk, Edward A ^b   Murdoch, William J ^b   Zhan, Yihong ^a   Isaak, Dale D ^b   Radosz, Maciej ^a   Shen, Youqing ^a  

^a UNIVERSITY OF WYOMING   (United States)

^b UNIVERSITY OF WYOMING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCK COPOLYMERS; NANOSTRUCTURED MATERIALS; PH EFFECTS; POLYETHYLENE GLYCOLS; SOLVENTS; SYNTHESIS (CHEMICAL);

ANTICANCER EFFICACIES; CISPLATIN-LOADED NANOPARTICLES; CYTOPLASMIC RELEASE; NANOPARTICLES;

ONCOLOGY;

CISPLATIN; COPOLYMER; MACROGOL; POLY(ETHYL METHACRYLATE); POLY[2 (N,N DIETHYLAMINO)ETHYL METHACRYLATE]; POLYCAPROLACTONE; POLYMETHACRYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; AQUAPLAST, CAPROLACTONE; MACROGOL DERIVATIVE; METHACRYLIC ACID DERIVATIVE; NANOMATERIAL; NYLON; POLY(2 (DIETHYLAMINO)ETHYL METHACRYLATE); POLY(2-(DIETHYLAMINO)ETHYL METHACRYLATE); POLYESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CHEMICAL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RELEASE; DRUG RESPONSE; ENCAPSULATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE TUMOR; MOUSE; NANOPARTICLE; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ANIMAL; CANCER TRANSPLANTATION; CHEMISTRY; DRUG DELIVERY SYSTEM; FEMALE; NEOPLASM; TUMOR CELL LINE;

ANIMALIA;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; METHACRYLATES; MICE; NANOSTRUCTURES; NEOPLASM TRANSPLANTATION; NEOPLASMS; NYLONS; POLYESTERS; POLYETHYLENE GLYCOLS;

EID: 33645529852     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm050902y     Document Type: Article

References (45)

1. Omura, G. A.; Brady, M. F. Obstet. Gynecol. (N. Y.) 1993, 81, 641.
2. Naora, H.; Montell, D. J. Nat. Rev. Cancer 2005, 5, 355.
3. Agarwal, R.; Kaye, S. B. Nat. Rev. Cancer 2003, 3, 502.
4. Gottesman, M. M. Annu. Rev. Med. 2002, 53, 615.
5. Doyle, L. A.; Ross, D. D. Oncogene 2003, 22, 7340.
6. Duvvuri, M.; Krise, J. P. Front. Biosci. 2005, 10, 1499.
7. Moses, M. A.; Brem, H.; Langer, R. Cancer Cell 2003, 4, 337.
8. David, A.; Kopeckova, P.; Minko, T.; Rubinstein, A.; Kopecek, J. Eur. J. Cancer 2004, 40, 148.
9. Dharap, S. S.; Qiu, B.; Williams, G. C.; Sinko, P.; Stein, S.; Minko, T. J. Controlled Release 2003, 91, 61.
10. Gillies, E. R.; Frechet, J. M. J. Drug Discovery Today 2005, 10, 35.
11. Vail, D. M.; Amantea, M. A.; Colbern, G. T.; Martin, F. J.; Hilger, R. A.; Working, P. K. Semin. Oncol. 2004, 31(6, Suppl. 13), 16.
12. Torchilin, V. P. Nat. Rev. Drug Discovery 2005, 4, 145.
13. Kwon, G. S. Crit. Rev. Ther. Drug Carrier Syst. 1998, 15, 481.
14. Yang, L.; Alexandridis, P. Curr. Opin. Colloid Interface Sci. 2000, 5, 132.
15. Brannon-Peppas, L.; Blanchette, J. O. Adv. Drug Delivery Rev. 2004, 56, 1649.
16. Panyam, J.; Labhasetwar, V. Adv. Drug Delivery Rev. 2003, 55, 329.
17. Maeda, M.; Kumano, A.; Tirrell, D. A. J. Am. Chem. Soc. 1988, 110, 7459.
18. Chen, Q.; Tong, S.; Dewhirst, M. W.; Yuan, F. Mol. Cancer Ther. 2004, 3, 1311.
19. Lindner, L. H.; Eichhorn, M. E.; Eibl, H.; Teichert, N.; Schmitt-Sody, M.; Issels, R. D.; Dellian, M. Clin. Cancer Res. 2004, 10, 2168.
20. Needham, D.; Anyarambhatla, G.; Kong, G.; Dewhirst, M. W. Cancer Res. 2000, 60, 1197.
21. Gillies, E. R.; Frechet, J. M. J. Bioconjugate Chem. 2005, 16, 361.
22. Kamada, H.; Tsutsumi, Y.; Yoshioka, Y.; Yamamoto, Y.; Kodaira, H.; Tsunoda, S.; Okamoto, T.; Mukai, Y.; Shibata, H.; Nakagawa, S.; Mayumi, T. Clin. Cancer Res. 2004, 10, 2545.
23. Schmid, S.; Fuchs, R.; Kielian, M.; Helenius, A.; Mellman, I. J. Cell Biol. 1989, 108, 1291.
24. Barret, A.; Heath, M. In Lysosomes: A Laboratory Handbook, 2nd ed.; Dingle, J., Ed.; North-Holland: New York, 1977.
25. Lee, E. S.; Na, K.; Bae, Y. H. J. Controlled Release 2005, 103, 405.
26. Lee, E. S.; Na, K.; Bae, Y. H. J. Controlled Release 2003, 90, 103.
27. Lee, E. S.; Shin, H. J.; Na, K.; Bae, Y. H. J. Controlled Release 2003, 90, 363.
28. Na, K.; Lee, K. H.; Bae, Y. H. J. Controlled Release 2004, 97, 513.
29. Na, K.; Bae, Y. H. Pharm. Res. 2002, 19, 681.
30. Kang, S. I.; Na, K.; Bae, Y. H. Macromol. Symp. 2001, 172, 149.
31. Helmlinger, G.; Yuan, F.; Dellian, M.; Jain, R. K. Nat. Med. 1997, 3, 177;
32. Jain, R. K. J. Controlled Release 2001, 74, 7.
33. Xu, P.; Tang, H.; Li, S.; Ren, J.; Van Kirk, E. A.; Murdoch, W. J.; Radosz, M.; Shen, Y. Biomacromolecules 2004, 5, 1736.
34. Dubois, P.; Jerome, R.; Teyssie, P. Macromolecules 1991, 24, 977.
35. Liu, S.; Weaver, J. V. M.; Save, M.; Armes, S. P. Langmuir 2002, 18, 8350.
36. Shen, Y.; Zhu, S.; Zeng, F.; Pelton, R. Macromolecules 2000, 33, 5399.
37. van Steenis, J. H.; van Maarseveen, E. M.; Verbaan, F. J.; Verrijk, R.; Crommelin, D. J. A.; Storm, G.; Hennink, W. E. J. Controlled Release 2003, 87, 167.
38. Van de Wetering, P.; Moret, E. E.; Schuurmans-Nieuwenbroek, N. M. E.; van Steenbergen, M. J.; Hennink, W. E. Bioconjugate Chem. 1999, 10, 589.
39. Yokoyama, M. Drug Delivery Syst. 1999, 14, 449.
40. Ameller, T.; Marsaud, V.; Legrand, P.; Gref, R.; Barratt, G.; Renoir, J.-M. Pharm. Res. 2003, 20, 1063.
41. Wenclawiak, B. W.; Wollmann, M. J. Chromatgr., A 1996, 724, 317.
42. Yoshikawa, A.; Santa, R.; Matsubara, T.; Mizuno, K. Kobe J. Med. Sci. 1997, 43, 109.
43. Lu, Y.; Low, P. S. Adv. Drug Delivery Rev. 2002, 54, 675.
44. Volker, P.; Grundker, C.; Schmidt, O.; Schulz, K. D.; Emons, G. Am. J. Obstet. Gynecol. 2002, 186, 171.
45. Fonseca, C.; Simoes, S.; Gaspar, R. J. Controlled Release 2002, 83, 273.